Effects of T cell leptin signaling on systemic glucose tolerance and T cell responses in obesity
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0286470 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Kaitlin Kiernan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Duke University School of Medicine, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Glucose Intolerance, Leptin. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Background/Objectives Leptin is an adipokine secreted in proportion to adipocyte mass and is therefore increased in obesity. Leptin signaling has been shown to directly promote inflammatory T helper 1 (Th1) and T helper 17 (Th17) cell number and function. Since T cells have a critical role in driving inflammation and systemic glucose intolerance in obesity, we sought to determine the role of leptin signaling in this context.
Methods
Male and female T cell-specific leptin receptor knockout mice and littermate controls were placed on low-fat diet or high-fat diet to induce obesity for 18 weeks. Weight gain, serum glucose levels, systemic glucose tolerance, T cell metabolism, and T cell differentiation and cytokine production were examined.
Results
In both male and female mice, T cell-specific leptin receptor deficiency did not reverse impaired glucose tolerance in obesity, although it did prevent impaired fasting glucose levels in obese mice compared to littermate controls, in a sex dependent manner. Despite these minimal effects on systemic metabolism, T cell-specific leptin signaling was required for changes in T cell metabolism, differentiation, and cytokine production observed in mice fed high-fat diet compared to low-fat diet. Specifically, we observed increased T cell oxidative metabolism, increased CD4 + T cell IFN-γ expression, and increased proportion of T regulatory (Treg) cells in control mice fed high-fat diet compared to low-fat diet, which were not observed in the leptin receptor conditional knockout mice, suggesting that leptin receptor signaling is required for some of the inflammatory changes observed in T cells in obesity.
Conclusions
T cell-specific deficiency of leptin signaling alters T cell metabolism and function in obesity but has minimal effects on obesity-associated systemic metabolism. These results suggest a redundancy in cytokine receptor signaling pathways in response to inflammatory signals in obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Duke University School of Medicine, Durham, North Carolina, United States of America.
- Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.
- Department of Nutrition, University of North Carolina School of Medicine and Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America.
ORCID-Profile: Nancie J MacIver
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Kiernan, K., Nichols, A. G., Alwarawrah, Y., & MacIver, N. J. (2023). Effects of T cell leptin signaling on systemic glucose tolerance and T cell responses in obesity. PLOS ONE. https://doi.org/10.1371/journal.pone.0286470
Vancouver
Kiernan K, Nichols AG, Alwarawrah Y, MacIver NJ. Effects of T cell leptin signaling on systemic glucose tolerance and T cell responses in obesity. PLOS ONE. 2023. doi:10.1371/journal.pone.0286470
BibTeX
@article{Kiernan2023,
author = {Kiernan, Kaitlin and Nichols, Amanda G and Alwarawrah, Yazan and MacIver, Nancie J},
title = {Effects of T cell leptin signaling on systemic glucose tolerance and T cell responses in obesity},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0286470}
}
EUVIMED